Corcept Therapeutics Inc (CORT)
54.63
-2.05
(-3.62%)
USD |
NASDAQ |
Mar 28, 16:00
58.79
+4.16
(+7.61%)
After-Hours: 20:00
Corcept Therapeutics Profit Margin (Quarterly): 16.90% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 39.44% |
| Nektar Therapeutics | 24.89% |
| Supernus Pharmaceuticals Inc | 8.80% |
| Bristol-Myers Squibb Co | 0.58% |
| ACADIA Pharmaceuticals Inc | 55.37% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.78% |
| Return on Assets | 19.52% |
| Return on Invested Capital | 23.78% |
| Gross Profit Margin (Quarterly) | 98.37% |
| Operating Margin (Quarterly) | 13.89% |
| Return on Net Operating Assets | 179.3% |